Summary: H.R.4629 — 116th Congress (2019-2020)All Information (Except Text)

There is one summary for H.R.4629. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (10/08/2019)

Star Rating for Biosimilars Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish quality measures regarding biosimilar biological products under the five-star performance rating system for Medicare Advantage plans. The measures must assess the level of access that plans provide to covered biosimilars, including with respect to formularies, cost-sharing, and utilization management.

The CMS must also incorporate such measures into similar rating systems for plans under the Medicare prescription drug benefit.